Burkoň et al., 2022 - Google Patents
Stereotactic Body Radiotherapy (SBRT) of Pancreatic Cancer—A Critical Review and Practical ConsiderationBurkoň et al., 2022
View HTML- Document ID
- 10379235532170911144
- Author
- Burkoň P
- Trna J
- Slávik M
- Němeček R
- Kazda T
- Pospíšil P
- Dastych M
- Eid M
- Novotný I
- Procházka T
- Vrzal M
- Publication year
- Publication venue
- Biomedicines
External Links
Snippet
Pancreatic cancer is the third leading cause of cancer death in the developed world and is predicted to become the second by 2030. A cure may be achieved only with surgical resection of an early diagnosed disease. Surgery for more advanced disease is challenging …
- 238000001959 radiotherapy 0 title abstract description 59
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1077—Beam delivery systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/103—Treatment planning systems
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/418—Evaluating particular organs or parts of the immune or lymphatic systems lymph vessels, ducts or nodes
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rogowski et al. | Feasibility and early clinical experience of online adaptive MR-guided radiotherapy of liver tumors | |
Burkoň et al. | Stereotactic Body Radiotherapy (SBRT) of Pancreatic Cancer—A Critical Review and Practical Consideration | |
Kim et al. | Stereotactic body radiation therapy in patients with pelvic recurrence from rectal carcinoma | |
Cellini et al. | Basics and frontiers on pancreatic cancer for radiation oncology: target delineation, SBRT, SIB technique, MRgRT, particle therapy, immunotherapy and clinical guidelines | |
El Shafie et al. | Pre-operative versus post-operative radiosurgery of brain metastases—volumetric and dosimetric impact of treatment sequence and margin concept | |
Kim et al. | Does risk-adapted proton beam therapy have a role as a complementary or alternative therapeutic option for hepatocellular carcinoma? | |
Moningi et al. | Stereotactic body radiation therapy in pancreatic cancer: the new frontier | |
Zamboglou et al. | Psma-pet/mri-based focal dose escalation in patients with primary prostate cancer treated with stereotactic body radiation therapy (Hypofocal-sbrt): Study protocol of a randomized, multicentric phase iii trial | |
Randall et al. | Towards accurate and precise image-guided radiotherapy: clinical applications of the MR-Linac | |
Owen et al. | Locoregional therapy for intrahepatic cholangiocarcinoma | |
Gutiérrez et al. | Current evidence for stereotactic body radiotherapy in lung metastases | |
Michalet et al. | Stereotactic MR-guided radiotherapy for adrenal gland metastases: first clinical results | |
Romesser et al. | Magnetic resonance imaging-guided adaptive radiotherapy for colorectal liver metastases | |
Falco et al. | Radiotherapy in pancreatic cancer: to whom, when, and how? | |
Weykamp et al. | Dosimetric Benefit of Adaptive magnetic resonance-guided stereotactic body Radiotherapy of Liver Metastases | |
Tubin et al. | Novel carbon Ion and proton partial irradiation of recurrent unresectable bulky tumors (particle-PATHY): early indication of effectiveness and safety | |
Cellini et al. | Modern management of esophageal cancer: Radio-oncology in neoadjuvancy, adjuvancy and palliation | |
Ladbury et al. | Clinical applications of magnetic resonance-guided radiotherapy: A narrative review | |
Serra et al. | SBRT for localized prostate cancer: CyberKnife vs. VMAT-FFF, a dosimetric study | |
Hawranko et al. | Investigation of isotoxic dose escalation and plan quality with TDABC analysis on a 0.35 T MR-Linac (MRL) system in ablative 5-fraction stereotactic magnetic resonance-guided radiation therapy (MRgRT) for primary pancreatic cancer | |
Hölscher et al. | Local control after locally ablative, image-guided Radiotherapy of Oligometastases identified by Gallium-68-PSMA-Positron Emission Tomography in Castration-Sensitive prostate Cancer patients (OLI-P) | |
Mohamad et al. | The evolving role of stereotactic body radiation therapy for head and neck cancer: where do we stand? | |
Muelas-Soria et al. | The usefulness of adaptative radiotherapy in prostate cancer: how, when, and who? | |
Bordeau et al. | Stereotactic MR-guided radiotherapy for liver metastases: First results of the montpellier prospective registry study | |
Cantaloube et al. | Image-guided liver stereotactic body radiotherapy using VMAT and real-time adaptive tumor gating: evaluation of the efficacy and toxicity for hepatocellular carcinoma |